Aidoc raises $150M Series E. AI in 2,000 hospitals worldwide
Aidoc raises $150M Series E. AI in 2,000 hospitals worldwide
April 29, 2026. Aidoc - clinical AI - raised $150 million Series E. Lead Goldman Sachs Growth Equity. NVIDIA and SoftBank also invested. Total company funding - over $500 million. Already deployed in nearly 2,000 hospitals.
Aidoc is clinical AI - primarily medical imaging. AI looks at X-rays, CT scans, MRIs. It tells the doctor - here is a change requiring attention.
Scale:
- Nearly 2,000 hospitals worldwide using it
- 60 million clinical cases per year analyzed by their AI
- Over $500 million total funding (Series E is the second big round in less than a year)
- First in history FDA clearance for “comprehensive double-digit foundation model-based triage system” in clinical imaging
Investors in this round: Goldman Sachs Growth Equity (lead), General Catalyst, SoftBank Vision Fund 2, NVentures (NVIDIA VC).
What the FDA clearance means
Aidoc got the first FDA clearance in history for a foundation model in clinical imaging. Their CARE model can autonomously triage clinical cases. Not just suggest.
Concrete: the AI itself decides which case is urgent and pushed up the queue to a radiologist. Normal workflow: patient does CT, waits 4-6 hours for the radiologist to get to it. With Aidoc: AI looks in 30 seconds and if it detects something critical (e.g. brain hemorrhage, pulmonary embolism) - jumps to first in the radiologist’s queue.
Why this is a big deal
This is real AI in health. Not a chatbot. Not “ChatGPT diagnoses.” A specialized model doing one thing better than a human.
Plus the business angle: hospital paying $X/month for Aidoc, saves $Y in radiologist time + avoids $Z in lawsuits for missed bleeds. ROI is clear.
My perspective
This is the model for what AI in health looks like in 2030. Not instead of a doctor - alongside a doctor. AI does screening, the doctor decides.
Your radiologist earns $200k/year. Aidoc costs a fraction of that. Doesn’t mean radiologists lose jobs. Means radiologists handle 3x more patients at the same salary.
Goldman Sachs doesn’t invest $150M in a startup without global ambitions.
Sources
- Axios - “Exclusive: Clinical AI provider Aidoc raises $150M Series E” (Apr 29, 2026)
- Aidoc - “Aidoc Raises $150 Million Series E Led by Goldman Sachs” (Apr 29, 2026)
- Goldman Sachs Asset Management - “Aidoc Raises $150M Series E”
- Radiology Business - “Radiology vendor Aidoc raises $150M from Goldman Sachs and others”